β-catenin inhibits promyelocytic leukemia protein tumor suppressor function in colorectal cancer cells

Gastroenterology

Volumn 142, Issue 3, 2012, Pages 572-581

  Satow, Reiko ^a,b   Shitashige, Miki ^a   Jigami, Takafumi ^a   Fukami, Kiyoko ^b   Honda, Kazufumi ^a   Kitabayashi, Issay ^a   Yamada, Tesshi ^a  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^b TOKYO UNIVERSITY OF PHARMACY AND LIFE SCIENCES   (Japan)

Author keywords

Colorectal Cancer; PML; TCF4; Wnt Signaling

Indexed keywords

BETA CATENIN; NUCLEAR PROTEIN; PROMYELOCYTIC LEUKEMIA PROTEIN; PROMYELOCYTIC LEUKEMIA PROTEIN 4; RAN BINDING PROTEIN 2; SUMO PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CELL COMPARTMENTALIZATION; CELL NUCLEUS INCLUSION BODY; COLORECTAL CANCER; CONTROLLED STUDY; HUMAN; HUMAN CELL; MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SUMOYLATION;

EID: 84857574310     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2011.11.041     Document Type: Article

References (47)

1. K.W. Kinzler, B. Vogelstein Lessons from hereditary colorectal cancer Cell 87 1996 159 170
2. P.J. Morin, A.B. Sparks, V. Korinek Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC Science 275 1997 1787 1790
3. A.B. Sparks, P.J. Morin, B. Vogelstein Mutational analysis of the APC/beta-catenin/Tcf pathway in colorectal cancer Cancer Res 58 1998 1130 1134
4. N. Barker, P.J. Morin, H. Clevers The yin-yang of TCF/beta-catenin signaling Adv Cancer Res 77 2000 1 24
5. M. Shitashige, S. Hirohashi, T. Yamada Wnt signaling inside the nucleus Cancer Sci 99 2008 631 637
6. M. Idogawa, T. Yamada, K. Honda Poly(ADP-ribose) polymerase-1 is a component of the oncogenic T-cell factor-4/beta-catenin complex Gastroenterology 128 2005 1919 1936
7. M. Idogawa, M. Masutani, M. Shitashige Ku70 and poly(ADP-ribose) polymerase-1 competitively regulate beta-catenin and T-cell factor-4-mediated gene transactivation: possible linkage of DNA damage recognition and Wnt signaling Cancer Res 67 2007 911 918
8. S. Sato, M. Idogawa, K. Honda beta-catenin interacts with the FUS proto-oncogene product and regulates pre-mRNA splicing Gastroenterology 129 2005 1225 1236
9. M. Shitashige, Y. Naishiro, M. Idogawa Involvement of splicing factor-1 in beta-catenin/T-cell factor-4-mediated gene transactivation and pre-mRNA splicing Gastroenterology 132 2007 1039 1054
10. Y. Hayashida, K. Honda, M. Idogawa E-cadherin regulates the association between beta-catenin and actinin-4 Cancer Res 65 2005 8836 8845
11. M. Shitashige, R. Satow, K. Honda Regulation of Wnt signaling by the nuclear pore complex Gastroenterology 134 2008 1961 1971 1971 e14
12. A. Kakizuka, W.H. Miller Jr, K. Umesono Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RAR alpha with a novel putative transcription factor, PML Cell 66 1991 663 674
13. H. de The, C. Lavau, A. Marchio The PML-RAR alpha fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR Cell 66 1991 675 684
14. Z.G. Wang, L. Delva, M. Gaboli Role of PML in cell growth and the retinoic acid pathway Science 279 1998 1547 1551
15. F. Piazza, C. Gurrieri, P.P. Pandolfi The theory of APL Oncogene 20 2001 7216 7222
16. A. Melnick, J.D. Licht Deconstructing a disease: RARalpha, its fusion partners, and their roles in the pathogenesis of acute promyelocytic leukemia Blood 93 1999 3167 3215
17. P. Salomoni, P.P. Pandolfi The role of PML in tumor suppression Cell 108 2002 165 170
18. R. Bernardi, A. Papa, P.P. Pandolfi Regulation of apoptosis by PML and the PML-NBs Oncogene 27 2008 6299 6312
19. P. Salomoni, B.J. Ferguson, A.H. Wyllie New insights into the role of PML in tumour suppression Cell Res 18 2008 622 640
20. C. Labbaye, M. Valtieri, F. Grignani Expression and role of PML gene in normal adult hematopoiesis: functional interaction between PML and Rb proteins in erythropoiesis Oncogene 18 1999 3529 3540
21. A. Guo, P. Salomoni, J. Luo The function of PML in p53-dependent apoptosis Nat Cell Biol 2 2000 730 736
22. R. Bernardi, I. Guernah, D. Jin PML inhibits HIF-1alpha translation and neoangiogenesis through repression of mTOR Nature 442 2006 779 785
23. Z.G. Wang, D. Ruggero, S. Ronchetti PML is essential for multiple apoptotic pathways Nat Genet 20 1998 266 272
24. E.M. Rego, P.P. Pandolfi Analysis of the molecular genetics of acute promyelocytic leukemia in mouse models Semin Hematol 38 2001 54 70
25. C.M. Cabrera, P. Jimenez, A. Concha Promyelocytic leukemia (PML) nuclear bodies are disorganized in colorectal tumors with total loss of major histocompatibility complex class I expression and LMP7 downregulation Tissue Antigens 63 2004 446 452
26. C. Gurrieri, P. Capodieci, R. Bernardi Loss of the tumor suppressor PML in human cancers of multiple histologic origins J Natl Cancer Inst 96 2004 269 279
27. L.A. Nguyen, P.P. Pandolfi, Y. Aikawa Physical and functional link of the leukemia-associated factors AML1 and PML Blood 105 2005 292 300
28. M. Shitashige, R. Satow, T. Jigami Traf2- and Nck-interacting kinase is essential for Wnt signaling and colorectal cancer growth Cancer Res 70 2010 5024 5033
29. W. Condemine, Y. Takahashi, J. Zhu Characterization of endogenous human promyelocytic leukemia isoforms Cancer Res 66 2006 6192 6198
30. K. Jensen, C. Shiels, P.S. Freemont PML protein isoforms and the RBCC/TRIM motif Oncogene 20 2001 7223 7233
31. E. Duprez, A.J. Saurin, J.M. Desterro SUMO-1 modification of the acute promyelocytic leukaemia protein PML: implications for nuclear localisation J Cell Sci 112 1999 381 393
32. T.H. Shen, H.K. Lin, P.P. Scaglioni The mechanisms of PML-nuclear body formation Mol Cell 24 2006 331 339
33. C. Gao, C.C. Ho, E. Reineke Histone deacetylase 7 promotes PML sumoylation and is essential for PML nuclear body formation Mol Cell Biol 28 2008 5658 5667
34. M.H. Tatham, S. Kim, E. Jaffray Unique binding interactions among Ubc9, SUMO and RanBP2 reveal a mechanism for SUMO paralog selection Nat Struct Mol Biol 12 2005 67 74
35. N. Saitoh, Y. Uchimura, T. Tachibana In situ SUMOylation analysis reveals a modulatory role of RanBP2 in the nuclear rim and PML bodies Exp Cell Res 312 2006 1418 1430
36. K. Petrie, A. Zelent Marked for death Nat Cell Biol 10 2008 507 509
37. S. Zhong, S. Muller, S. Ronchetti Role of SUMO-1-modified PML in nuclear body formation Blood 95 2000 2748 2752
38. V. Fogal, M. Gostissa, P. Sandy Regulation of p53 activity in nuclear bodies by a specific PML isoform EMBO J 19 2000 6185 6195
39. H. Zhu, L. Wu, C.G. Maki MDM2 and promyelocytic leukemia antagonize each other through their direct interaction with p53 J Biol Chem 278 2003 49286 49292
40. R. Bernardi, P.P. Scaglioni, S. Bergmann PML regulates p53 stability by sequestering Mdm2 to the nucleolus Nat Cell Biol 6 2004 665 672
41. C. Fu, K. Ahmed, H. Ding Stabilization of PML nuclear localization by conjugation and oligomerization of SUMO-3 Oncogene 24 2005 5401 5413
42. A.M. Ishov, A.G. Sotnikov, D. Negorev PML is critical for ND10 formation and recruits the PML-interacting protein daxx to this nuclear structure when modified by SUMO-1 J Cell Biol 147 1999 221 234
43. V. Lallemand-Breitenbach, M. Jeanne, S. Benhenda Arsenic degrades PML or PML-RARalpha through a SUMO-triggered RNF4/ubiquitin-mediated pathway Nat Cell Biol 10 2008 547 555
44. E.L. Reineke, M. Lam, Q. Liu Degradation of the tumor suppressor PML by Pin1 contributes to the cancer phenotype of breast cancer MDA-MB-231 cells Mol Cell Biol 28 2008 997 1006
45. V. Korinek, N. Barker, P. Moerer Depletion of epithelial stem-cell compartments in the small intestine of mice lacking Tcf-4 Nat Genet 19 1998 379 383
46. K. Ito, R. Bernardi, A. Morotti PML targeting eradicates quiescent leukaemia-initiating cells Nature 453 2008 1072 1078
47. V. Lallemand-Breitenbach, J. Zhu, F. Puvion Role of promyelocytic leukemia (PML) sumolation in nuclear body formation, 11S proteasome recruitment, and As2O3-induced PML or PML/retinoic acid receptor alpha degradation J Exp Med 193 2001 1361 1371